Search results
352 results found
Genome edited babies: An unexpected realityBlogInternationally, there is a general agreement that genome editing of human embryos is not ready for the clinic.
Genetic information about disease risks – does knowledge empower?BlogMany factors influence a person’s risk of developing diseases such as cancer and heart disease, of which our genes are but one.
Rethinking vaccination with RNA vaccinesBlogDeveloping effective flu vaccines is a major annual challenge. Can RNA vaccines help us do better against this and other major diseases?
What can personalised health technologies offer ‘healthy’ adults?BlogHow could new technologies help Chloe to change her health behaviours? Read the update from the final My Healthy Future life stage workshop.
Making the most of data for personalised medicineBlogData is a common theme across many of the technologies covered in our recent report - Dr Sobia Raza examines the implications
Artificial intelligence policy as a contact sportPast eventThe 2024 WYNG-Hatton lecture from one of the masters of policy influencing, Dr Eric Meslin, considered why bioethics and governance need to up their game in the health sector
Regulating algorithms in healthcare: IP and liabilityBlog2018 is the year the UK has consolidated its developing AI healthcare industry.
Born healthy: tackling the burden of birth defectsCase studyThe Born Healthy Toolkit supports healthcare professionals in tackling the burden of birth defects around the world.
Using genomics to combat infectious diseaseCase studyCase study: how implementing pathogen genomic technologies could transform the management of infectious disease.
Brokering the conversationCase studyAs part of its ‘Big Conversation’, Genomics England commissioned PHG Foundation to arrange a meeting between Genomics England and clinicians to discuss policy development around the introduction of genomic testing into routine clinical service.